That is necessary, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient. To put it simply, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental process (last year). But now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're developed to do. This was an advancement practically no one saw. However it's going to have profound implications for curing illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment chances in this space, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (democratic republic). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe substantially before going higher - jeff brown investor prediction. I have actually been covering bitcoin for a long time now. One of the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily informing readers. But that's not the big question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. genetic sequencer stock jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are so many terrific private business on the edge of striking the public markets And I've been dealing with a brand-new way for you to invest even prior to these companies go public.
This opportunity has been constructing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to book your spot free of charge.
Emma Walsh here, managing editor of the Diary. Regular Diary readers understand that tech isn't our typical beat (jeff brown market predictions). And when it concerns tech investing, we leave it to the professionals. The good news is, we have a number of such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (artificial intelligence). In truth, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and anticipate what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing rapid growth and producing amazing opportunities for financiers. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. democratic republic. But regardless of what numerous readers might think, this is a pattern that's just beginning. Even though the COVID-19 pandemic disrupted supply chains last year, an impressive 250 million 5G-enabled devices were still sold.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (biotech stocks jeff brown). Losing two months of manufacturing and sales really impacts how many 5G gadgets are offered in the calendar year. When you consider all of that, selling 250 million systems is remarkable. More significantly, the delays brought on by the pandemic produced a lots of bottled-up demand. Which need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - biotech stock. And that's not my only 5G prediction When I have actually discussed 5G in the past, I've explained its 3 various stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Stage Three, 5G services begin to be used (jeff brown prediction). That's when we start to see applications running on 5G networks. Think about things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase Three by this summertime. This begins something of a virtuous cycle: A lot of people do not really care about the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open up a suite of extraordinary applications: self-driving cars, the Internet of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment opportunities going forward will be enormous. Stepping away from 5G, the next important innovation I predict in 2021 is CRISPR genetic editing. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it's one of the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a similar concept but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can correct these "typos." For years, CRISPR was mostly a niche innovation that wasn't well comprehended. And during that time, there were actually just three business running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing extraordinary returns. This whole industry is efficiently a greenfield opportunity.
There's room for numerous business to exist in this space. jeff brown investment prediction. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things taking place at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software application can accurately forecast the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is necessary since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error procedure. But now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're created to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however several drug treatments produced using this technology. This was among those developments that nearly nobody saw. But it's going to have profound implications for curing illness. And, of course, there will be lots of financial investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back possibly substantially prior to going greater. I've been covering bitcoin for a very long time now. Among the very first research reports I ever released was on bitcoin - genetic sequencing companies jeff brown. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. artificial intelligence. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date since February 2021, however we could not individually confirm this claim. Given Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like ability to pick winning innovation stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional perspective on the market. He's always on the hunt for new opportunities, and he shares many of his best choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully forecasted some of the most significant financial occasions of the past twenty years. Although he does not appear to launch his choices to the general public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it right each time, however Jeff Brown's accurate forecasts have actually earned him legions of dedicated followers. That says a lot about his ability. The Near Future Report is released by Brownstone Research study, a prominent financial research study publisher. Brownstone Research uses numerous research study services with a wide array of specializations - united states.
The business is also associated with Bonner & Partners, another well-respected research publisher - jeff brown prediction. On its site, Brownstone says its objective is to offer retail investors with professional-grade research: "For too long, the best investment research study has actually not been available to specific financiers. It has been normally booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. self-driving cars. The mission of Brownstone Research is to make that type of proprietary research study readily available to any financiers seeking to acquire an edge in the marketplaces. The goal is simple to provide distinct and profitable financial investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also acts as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After decades of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout many of America. If you understand even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. korean actress. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown thinks S.A.V. the legacy report predictions. could be "the biggest trend of the 2020s, and he's not alone. Examine out these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying two advanced innovations: synthetic intelligence and electrical cars and trucks. Musk hopes the mix will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the vehicle market's Holy Grail. As you know, electrical automobiles and self-driving automobile stocks have been huge this year, but the Wall Street device has been big on buzz without much tangible outcome. Despite a drastic boost in competition over the previous couple of years, Brown still thinks Musk has the finest possibility of putting it all together.
tech might be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transport. Generally, this innovation would enable you to lease out your vehicle as a self-governing, self-driving taxi when you're not using it. You just get out of the car and press a button on an app that informs the automobile to "join the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large piece of the revenues. It sounds crazy, however it might be closed than you think.